ACALCULUS LYMPHOEOSINOPHILIC CHOLECYSTITIS ASSOCIATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY

被引：0
|
作者：
CHUNGPARK, M
KIM, B
MARMOLYA, G
KARLINS, N
WOJCIK, E
机构：
[1] CASE WESTERN RESERVE UNIV,METROHEALTH MED CTR,DEPT SURG,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,METROHEALTH MED CTR,DEPT RADIOL,CLEVELAND,OH 44106
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 1990年 / 114卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1073 / 1075
页数：3
相关论文
共 50 条
  • [21] TOXICITY OF IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    MIER, JW
    ARONSON, FR
    NUMEROF, RP
    VACHINO, G
    ATKINS, MB
    PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH, 1988, 7 (06): : 459 - 476
  • [22] CHARACTERISTICS OF INTERLEUKIN-6-ENHANCED LYMPHOKINE-ACTIVATED KILLER-CELL FUNCTION
    IHO, S
    SHAU, H
    GOLUB, SH
    CELLULAR IMMUNOLOGY, 1991, 135 (01) : 66 - 77
  • [23] GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY BY LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND TUMOR-CELLS
    YAMAMOTO, S
    HOON, DSB
    CHANDLER, P
    SCHMID, I
    IRIE, RF
    CELLULAR IMMUNOLOGY, 1990, 128 (02) : 516 - 527
  • [24] PHYTOCHEMICALS POTENTIATE INTERLEUKIN-2 GENERATED LYMPHOKINE-ACTIVATED KILLER-CELL CYTOTOXICITY AGAINST MURINE RENAL-CELL CARCINOMA
    WANG, Y
    QIAN, XJ
    HADLEY, HR
    LAU, BHS
    MOLECULAR BIOTHERAPY, 1992, 4 (03) : 143 - 146
  • [25] PROLONGATION OF SERUM HALF-LIFE OF INTERLEUKIN-2 AND AUGMENTATION OF LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY BY PEPSTATIN IN MICE
    OHNISHI, H
    LIN, KM
    CHU, TM
    CANCER RESEARCH, 1990, 50 (04) : 1107 - 1112
  • [26] DO PHENOTHIAZINES CONTRIBUTE TO TUMOR REGRESSIONS IN LYMPHOKINE-ACTIVATED KILLER-CELL INTERLEUKIN-2 TREATMENTS OF RENAL-CELL CANCER
    SAUTER, C
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 241 - 242
  • [27] AUGMENTATION OF LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY BY LENTINAN
    TANI, M
    TANIMURA, H
    YAMAUE, H
    TSUNODA, T
    IWAHASHI, M
    NOGUCHI, K
    TAMAI, M
    HOTTA, T
    MIZOBATA, S
    ANTICANCER RESEARCH, 1993, 13 (5C) : 1773 - 1776
  • [28] LYMPHOKINE-ACTIVATED KILLER-CELL TRAFFIC IN METASTATIC MELANOMA
    DUMMER, R
    SCHAFER, E
    EILLES, C
    BORNER, W
    BURG, G
    LANCET, 1991, 338 (8764): : 456 - 457
  • [29] INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELL THERAPY OF SOLID TUMORS - ANALYSIS OF TOXICITY AND MANAGEMENT GUIDELINES
    MARGOLIN, KA
    RAYNER, AA
    HAWKINS, MJ
    ATKINS, MB
    DUTCHER, JP
    FISHER, RI
    WEISS, GR
    DOROSHOW, JH
    JAFFE, HS
    ROPER, M
    PARKINSON, DR
    WIERNIK, PH
    CREEKMORE, SP
    BOLDT, DH
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) : 486 - 498
  • [30] PHASE IB TRIAL OF PENTOXIFYLLINE AND CIPROFLOXACIN IN PATIENTS TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    THOMPSON, JA
    BIANCO, JA
    BENYUNES, MC
    NEUBAUER, MA
    SLATTERY, JT
    FEFER, A
    CANCER RESEARCH, 1994, 54 (13) : 3436 - 3441
12345